These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 1282464

  • 1. Autonomic effects of antiarrhythmic drugs and their importance.
    Lombardi F, Torzillo D, Sandrone G, Dalla Vecchia L, Cappiello E.
    Eur Heart J; 1992 Nov; 13 Suppl F():38-43. PubMed ID: 1282464
    [No Abstract] [Full Text] [Related]

  • 2. Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
    Stramba-Badiale M, Lazzarotti M, Facchini M, Schwartz PJ.
    Am Heart J; 1994 Nov; 128(5):973-82. PubMed ID: 7524295
    [Abstract] [Full Text] [Related]

  • 3. [Antiarrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction (author's transl)].
    Klempt HW, Nayebagha A, Fabry E.
    Z Kardiol; 1982 May; 71(5):340-9. PubMed ID: 6180562
    [Abstract] [Full Text] [Related]

  • 4. [The characteristics of the autonomic regulation of the heart rate in patients with IHD and ventricular arrhythmias under obzidan therapy].
    Belogubets VI, Polevaia TIu, Afonskaia NI, Smetnev AS.
    Ter Arkh; 1994 May; 66(8):32-4. PubMed ID: 7527162
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta-blocking effect of propafenone based on spectral analysis of heart rate variability.
    Lombardi F, Torzillo D, Sandrone G, Dalla Vecchia L, Finocchiaro ML, Bernasconi R, Cappiello E.
    Am J Cardiol; 1992 Oct 15; 70(11):1028-34. PubMed ID: 1357951
    [Abstract] [Full Text] [Related]

  • 7. Mexiletine and propafenone: a comparative study of monotherapy, low, and full dose combination therapy.
    Takanaka C, Nonokawa M, Machii T, Lee S, Kato H, Haruna M, Yabe S.
    Pacing Clin Electrophysiol; 1992 Nov 15; 15(11 Pt 2):2130-3. PubMed ID: 1279613
    [Abstract] [Full Text] [Related]

  • 8. [Treatment with mexiletine. Clinical and pharmacokinetic studies].
    Breithaupt H, Schmidt A.
    Klin Wochenschr; 1988 Jun 01; 66(11):475-81. PubMed ID: 2457131
    [Abstract] [Full Text] [Related]

  • 9. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
    Capucci A, Di Pasquale G, Boriani G, Carini G, Balducelli M, Frabetti L, Carozzi A, Finzi A, Pinelli G, Magnani B.
    Int J Clin Pharmacol Res; 1991 Jun 01; 11(1):23-33. PubMed ID: 1714885
    [Abstract] [Full Text] [Related]

  • 10. Combination of flecainide and mexiletine for the treatment of ventricular tachyarrhythmias.
    Jordaens LJ, Tavernier R, Vanmeerhaeghe X, Robbens E, Clement DL.
    Pacing Clin Electrophysiol; 1990 Sep 01; 13(9):1127-35. PubMed ID: 1700388
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long term inotropic effects of flecainide and propafenone.
    Henze E, Roth J, Haerer W, Adam WE, Stauch M.
    Eur J Nucl Med; 1988 Sep 01; 13(11):568-71. PubMed ID: 2450751
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathogenesis, recognition, and management of common cardiac arrhythmias. Part I: Ventricular premature beats and tachyarrhythmias.
    Alpert MA, Mukerji V, Bikkina M, Concannon MD, Hashimi MW.
    South Med J; 1995 Jan 01; 88(1):1-21. PubMed ID: 7529434
    [Abstract] [Full Text] [Related]

  • 16. [Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms].
    Mastropasqua F, Totaro P, Massari F, Pitzalis MV, Rizzon P.
    Cardiologia; 1998 Jun 01; 43(6):617-23. PubMed ID: 9675961
    [Abstract] [Full Text] [Related]

  • 17. Relation of diurnal variation of ventricular repolarization to ventricular ectopic activity and modification by sotalol.
    Hohnloser SH, Zabel M, Just H, Raeder EA.
    Am J Cardiol; 1993 Feb 15; 71(5):475-8. PubMed ID: 7679244
    [No Abstract] [Full Text] [Related]

  • 18. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
    Sarubbi B, Ducceschi V, Briglia N, Esposito R, Mayer MS, Scialdone A, Santangelo L, Iacono A.
    Cardiologia; 1996 Jul 15; 41(7):645-51. PubMed ID: 8983831
    [Abstract] [Full Text] [Related]

  • 19. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL.
    Minerva Cardioangiol; 1995 Oct 15; 43(10):449-57. PubMed ID: 8819814
    [Abstract] [Full Text] [Related]

  • 20. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
    Yeung-Lai-Wah JA, Murdock CJ, Boone J, Kerr CR.
    J Am Coll Cardiol; 1992 Sep 15; 20(3):547-51. PubMed ID: 1512331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.